Corbus Pharmaceuticals Holdings, Inc.
General ticker "CRBP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $119.7M (TTM average)
Corbus Pharmaceuticals Holdings, Inc. follows the US Stock Market performance with the rate: 27.2%.
Estimated limits based on current volatility of 3.5%: low 9.80$, high 10.52$
Factors to consider:
- Total employees count: 28 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Operational and conduct risks, Significant losses, Substantial financing needs, Third-party risks, Geopolitical risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.31$, 15.83$]
- 2026-12-31 to 2027-12-31 estimated range: [4.08$, 12.67$]
Financial Metrics affecting the CRBP estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -59.03 <= 0.07
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -4.45 < Investing cash flow per share per price, % of -1.50
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term CRBP quotes
Long-term CRBP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $45.08MM | $48.72MM | $85.31MM |
| Operating Income | $-45.08MM | $-48.72MM | $-85.31MM |
| Non-Operating Income | $0.47MM | $8.51MM | $6.77MM |
| Interest Expense | $3.86MM | $1.87MM | $0.00MM |
| R&D Expense | $31.17MM | $32.22MM | $70.09MM |
| Income(Loss) | $-44.60MM | $-40.21MM | $-78.54MM |
| Profit(Loss)* | $-44.60MM | $-40.21MM | $-78.54MM |
| Stockholders Equity | $-6.91MM | $142.43MM | $147.50MM |
| Assets | $28.27MM | $155.88MM | $168.19MM |
| Operating Cash Flow | $-36.10MM | $-41.79MM | $-64.49MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $35.64MM | $-121.31MM | $-1.64MM |
| Financing Cash Flow | $-2.82MM | $166.58MM | $77.43MM |
| Earnings Per Share** | $-10.31 | $-3.68 | $-5.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.